Status:
UNKNOWN
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study
Lead Sponsor:
Jaeb Center for Health Research
Collaborating Sponsors:
Juvenile Diabetes Research Foundation
University of Minnesota
Conditions:
Type1 Diabetes
Eligibility:
All Genders
7-17 years
Brief Summary
The purpose of this extension study is to continue to follow the participants who completed the CLVer RCT for up to 3 additional years. The goal for Cohort A is to evaluate the longer-term effects of ...
Detailed Description
Participants who complete the CLVer RCT will be eligible to enroll in the CLVer Extension Study. Informed consent and assent, when applicable, will be obtained. Participants will be contacted every 3 ...
Eligibility Criteria
Inclusion
- Completed CLVer RCT 12 month visit and willing to join observational extension.
Exclusion
Key Trial Info
Start Date :
May 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 18 2025
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT06177691
Start Date
May 7 2021
End Date
December 18 2025
Last Update
December 20 2023
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94304
2
Barbara Davis Center
Aurora, Colorado, United States, 80045
3
Yale University
New Haven, Connecticut, United States, 06511
4
Indiana University
Indianapolis, Indiana, United States, 46202